Breakthroughs in Neoadjuvant Therapies
When: Tuesday, March 25, 2014
Noon to 1:00 p.m. ET
Neoadjuvant therapy is given to shrink a tumor before surgery or any other primary treatment of early-stage breast cancer. During our free March webinar on neoadjuvant therapy, Carey K. Anders, MD, helped you
- learn what types of treatments are available before surgery: chemotherapy, hormonal therapy and targeted therapy
- understand the goals of neoadjuvant therapy and how the cancer’s response affects local and full-body treatments given after it
- discover why researchers are using neoadjuvant therapies to study new treatments in clinical trials and who may be able to partake
About Our Speaker
Carey K. Anders, MD is a clinician-scientist and an assistant professor of medicine at the University of North Carolina School of Medicine. She is a member of the UNC Lineberger Comprehensive Cancer Center and the UNC Breast Center, as well as national associations and organizations including the American Society of Clinical Oncology, Translational Breast Cancer Research Consortium and NCI Breast Cancer Metastases Working Group.
Her clinical efforts focus on the care of women with breast cancer, particularly young women and those who develop brain metastases. She is a translational researcher who designs both pre-clinical lab experiments and clinical trials to more effectively treat women with advanced triple-negative breast cancer.
Dr. Anders is the recipient of several honors and awards for her dedication to the practice of medicine and has published many articles on breast cancer.
This webinar was made possible in part due to the generous support of